Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes.

Authors	Liyun He, Huabing Zhang
Journal	The New England journal of medicine (N Engl J Med) Vol. 385 Issue 22 Pg. 2106-2107 (11 25 2021) ISSN: 1533-4406 [Electronic] United States
PMID	34818491 (Publication Type: Letter, Comment)
Chemical References	Glycated Hemoglobin A Hypoglycemic Agents efpeglenatide Proline
Topics	Diabetes Mellitus, Type 2 (complications, drug therapy) Glycated Hemoglobin Humans Hypoglycemic Agents (therapeutic use) Kidney Proline

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!